Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Landstar System, Inc. (“Landstar System”) (NASDAQ:LSTR).

Landstar System Unable to File 10-Q Due to Supply Chain Fraud Review

On April 25, 2025, Landstar System filed a Notification of Late Filing regarding its inability to file its Quarterly Report on Form 10-Q for the period ended March 29, 2025. Landstar System reported the need for additional time to complete its evaluation of certain accounting and internal control matters related to a previously disclosed supply chain fraud.

On this news, Landstar System’s stock price dropped more than 4% during intraday trading on April 25, 2025.

Investors of Lanstar System Stock May Have Legal Claims 

Landstar System shareholders are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

Landstar System investors can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX).

Aldeyra Stock Drops Significantly as FDA Rejects Reproxalap NDA, Citing Efficacy and Methodological Issues

On April 3, 2025, Aldeyra “. . . announce[d] that it had received a Complete Response Letter . . . from the U.S. Food & Drug Administration . . . regarding the Company’s resubmitted New Drug Application . . . for reproxalap, an investigational drug candidate, for the treatment of dry eye disease.”

The Company reported that the FDA’s letter “. . . stated that the NDA ‘failed to demonstrate efficacy in adequate and well controlled studies in treating ocular symptoms associated with dry eyes’ and that ‘at least one additional adequate and well controlled study to demonstrate a positive effect on the treatment of ocular symptoms of dry eye’ should be conducted.”

Aldeyra reported that “[t]he letter identified concerns with the data from the trial submitted to the NDA that may have affected interpretation of the results, which the FDA stated may be related to methodological issues, including a difference in baseline scores across treatment arms.”

On this news, Aldeyra’s stock price dropped more than 73% from a closing price of $5.32 on April 2, 2025 to $1.42 per share at the close of trading on April 3, 2025. 

Investors of Aldeyra Stock May Have Legal Claims 

Aldeyra shareholders are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

Aldeyra investors can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Ibotta, Inc. (“Ibotta”) (NYSE:IBTA).

Class Action Filed Against Ibotta

On April 17, 2025, a class action complaint alleging violations of federal securities laws was filed against Ibotta in United States District Court, District of Colorado (Case No. 1:25-cv-01213), on behalf of those who purchased or otherwise acquired publicly-traded Ibotta securities pursuant and/or traceable to the registration statement and related prospectus (the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (“IPO”).

The securities class action lawsuit seeks to recover compensable damages caused by the Ibotta Defendant’s alleged violations of the federal securities laws under the Securities Act of 1933.

The Registration Statement, according to the complaint, “. . . was negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and was not prepared in accordance with the rules and regulations governing its preparation.”

To review a copy of the complaint, please click Ibotta Class Action Complaint.

Ibotta Investors May Have Legal Claims 

Investors who acquired Ibotta securities pursuant and/or traceable to the company’s Registration Statement issued in connection with Ibotta’s IPO are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

Ibotta shareholders can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas BioPharma”) (NASDAQ:ZBIO).

Class Action Filed Against Zenas BioPharma 

On April 16, 2025, a class action complaint alleging violations of federal securities laws was filed against Zenas BioPharma in United States District Court, District of Massachusetts (Case No. 1:25-cv-10988), on behalf of investors who purchased or otherwise acquired Zenas BioPharma securities pursuant and/or traceable to the registration statement and related prospectus (the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO”). 

To review a copy of the complaint, please click ZBIO Class Action Complaint.

Zenas BioPharma Investors May Have Legal Claims 

Investors who acquired Zenas BioPharma securities pursuant and/or traceable to the company’s IPO are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

Zenas BioPharma shareholders can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of BigBear.ai Holdings, Inc. (“BigBear.ai” or “BigBear”) (NYSE:BBAI).

Class Action Lawsuit Filed Against BigBear.ai 

On April 11, 2025, a class action complaint was filed against BigBear.ai in United States District Court, Eastern District of Virginia (Case No. 1:25-cv-00623), on behalf of investors who acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the “Class Period”).

The class action seeks to recover damages caused by the BigBear.ai Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, against BigBear.ai and certain of its top officials.

Summary of the Class Action Allegations

According to the complaint, throughout the Class Period, the BigBear.ai Defendants made false and/or misleading statements and/or failed to disclose that BigBear maintained deficient accounting review policies related to the reporting and disclosure of certain non-routine, unusual, or complex transactions. As a result, BigBear incorrectly determined that the conversion option within the 2026 Convertible Notes qualified for the derivative scope exception under ASC 815-40 and failed to bifurcate the conversion option as required by ASC 815-15.

Allegedly, BigBear improperly accounted for the 2026 Convertible Notes, an error which caused BigBear to misstate various items in several of its previously issued financial statements which would likely need to be restated. 

BigBear Investors May Have Legal Claims 

BigBear.ai investors who acquired their securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the class action and receive a free, no-obligation evaluation of potential legal claims.

For direct inquiries, BigBear investors can contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ:TTGT).

TechTarget Unable to File its Annual Report on Form 10-K

In a March 31, 2025 “Notification of Late Filing,” TechTarget reported that it was unable to timely file its Annual Report on Form 10-K and “. . . is taking the extension period to further evaluate technical accounting matters arising while preparing its financial statements for the fiscal year ended December 31, 2024 . . . includ[ing] undertaking a technical assessment of the goodwill of the Industry Dive business, which was acquired in 2022.”

TechTarget also reported that it “. . . expects to record a pre-tax non-cash goodwill impairment charge related to the business in the range of approximately $70m to $110m in the year ended December 31, 2024.”

Following this news, TechTarget’s stock price fell from $14.81 per share on March 31, 2025 to $12.76 per share at the market’s close on April 1, 2025.

TechTarget Receives Nasdaq Notification Letter & Reports Certain Financial Statements Should No Longer Be Relied Upon Due to Material Errors 

On April 18, 2025, TechTarget reported that “[o]n April 17, 2025, the Company received a notification letter . . . from the Listing Qualifications Department of [Nasdaq] . . . stating that, because the Company failed to timely file its 2024 Form 10-K with the [SEC], the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) . . ., which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC.”

Moreover, the Company reported that “[d]uring the preparation of the Company’s financial statements for the fiscal year ended December 31, 2024, the Company’s management identified certain material errors in the Affected Financial Statements relating to certain technical accounting matters associated with goodwill impairment, changes in contingent consideration, and amortization of intangibles, including related tax impacts thereof. The Company also identified, and will correct in the restatements, other out-of-period and uncorrected misstatements.”

TechTarget also reported that “[a]ny previously issued or filed reports, earnings releases, and investor presentations or other communications including or describing the Affected Financial Statements and related financial information covering the Non-Reliance Periods should no longer be relied upon.”

Lastly, TechTarget reported that “[s]imilarly, the report of . . . PricewaterhouseCoopers LLP . . . accompanying the audited combined financial statements of the Informa Tech Digital Businesses of Informa PLC as of December 31, 2023 and 2022 and for the three years ended December 31, 2023, should no longer be relied upon.”

TechTarget Investors May Have Legal Claims 

TechTarget stock investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

For direct inquiries, TechTarget shareholders should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]